Your browser doesn't support javascript.
loading
18F-FDG PET/CT and radiolabeled leukocyte SPECT/CT imaging for the evaluation of cardiovascular infection in the multimodality context: ASNC Imaging Indications (ASNC I2) Series Expert Consensus Recommendations from ASNC, AATS, ACC, AHA, ASE, EANM, HRS, IDSA, SCCT, SNMMI, and STS.
Bourque, Jamieson M; Birgersdotter-Green, Ulrika; Bravo, Paco E; Budde, Ricardo P J; Chen, Wengen; Chu, Vivian H; Dilsizian, Vasken; Erba, Paola Anna; Gallegos Kattan, Cesia; Habib, Gilbert; Hyafil, Fabien; Khor, Yiu Ming; Manlucu, Jaimie; Mason, Pamela Kay; Miller, Edward J; Moon, Marc R; Parker, Matthew W; Pettersson, Gosta; Schaller, Robert D; Slart, Riemer H J A; Strom, Jordan B; Wilkoff, Bruce L; Williams, Adam; Woolley, Ann E; Zwischenberger, Brittany A; Dorbala, Sharmila.
Affiliation
  • Bourque JM; Cardiovascular Division and the Cardiovascular Imaging Center, Departments of Medicine and Radiology, University of Virginia Health System, Charlottesville, VA, USA. Electronic address: JMB8T@uvahealth.org.
  • Birgersdotter-Green U; Division of Cardiology, UC San Diego Health, San Diego, CA, USA.
  • Bravo PE; Divisions of Nuclear Medicine, Cardiothoracic Imaging and Cardiovascular Medicine, Director, Nuclear Cardiology and Cardiovascular Molecular Imaging, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Budde RPJ; Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
  • Chen W; University of Maryland School of Medicine, Department of Diagnostic Radiology and Nuclear Medicine, Baltimore, MD, USA.
  • Chu VH; Division of Infectious Diseases, Duke University School of Medicine, Durham, NC, USA.
  • Dilsizian V; University of Maryland School of Medicine, Department of Diagnostic Radiology and Nuclear Medicine, Baltimore, MD, USA.
  • Erba PA; Department of Medicine and Surgery University of Milano Bicocca and Nuclear Medicine, ASST Ospedale Papa Giovanni XXIII, Bergamo, Italy.
  • Gallegos Kattan C; Nuclear Cardiology, Yale University School of Medicine, New Haven, CT, USA.
  • Habib G; Cardiology Department, Hôpital La Timone, Marseille, France.
  • Hyafil F; Nuclear Cardiology and Nuclear Medicine Department, DMU IMAGINA, Hôpital Européen Georges-Pompidou, University of Paris, Paris, France.
  • Khor YM; Department of Nuclear Medicine and Molecular Imaging, Singapore General Hospital, Singapore.
  • Manlucu J; London Heart Rhythm Program, Western University, London Health Sciences Centre (University Hospital), London, Ontario, Canada.
  • Mason PK; Cardiovascular Medicine, University of Virginia Health System, Charlottesville, VA, USA.
  • Miller EJ; Nuclear Cardiology, Yale University School of Medicine, New Haven, CT, USA.
  • Moon MR; Division of Cardiothoracic Surgery, Baylor College of Medicine, Houston, TX, USA.
  • Parker MW; Echocardiography Laboratory, Division of Cardiovascular Medicine, University of Massachusetts T.H. Chan School of Medicine, Worcester, MA, USA.
  • Pettersson G; Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, OH, USA.
  • Schaller RD; Department of Cardiac Electrophysiology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Slart RHJA; Medical Imaging Centre, Department of Nucleare, Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, the Netherlands.
  • Strom JB; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Harvard Medical School, Boston, MA, USA.
  • Wilkoff BL; Cardiac Pacing & Tachyarrhythmia Devices, Department of Cardiovascular Medicine, Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
  • Williams A; Brigham and Women's Hospital, Boston, MA, USA.
  • Woolley AE; Division of Thoracic and Cardiovascular Surgery, Duke University Medical Center, Durham, NC, USA.
  • Zwischenberger BA; Brigham and Women's Hospital, Boston, MA, USA.
  • Dorbala S; Cardiovascular Imaging Program, Departments of Medicine and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Heart Rhythm ; 21(5): e1-e29, 2024 May.
Article in En | MEDLINE | ID: mdl-38466251
ABSTRACT
This document on cardiovascular infection, including infective endocarditis, is the first in the American Society of Nuclear Cardiology Imaging Indications (ASNC I2) series to assess the role of radionuclide imaging in the multimodality context for the evaluation of complex systemic diseases with multi-societal involvement including pertinent disciplines. A rigorous modified Delphi approach was used to determine consensus clinical indications, diagnostic criteria, and an algorithmic approach to diagnosis of cardiovascular infection including infective endocarditis. Cardiovascular infection incidence is increasing and is associated with high morbidity and mortality. Current strategies based on clinical criteria and an initial echocardiographic imaging approach are effective but often insufficient in complicated cardiovascular infection. Radionuclide imaging with 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (CT) and single photon emission computed tomography/CT leukocyte scintigraphy can enhance the evaluation of suspected cardiovascular infection by increasing diagnostic accuracy, identifying extracardiac involvement, and assessing cardiac implanted device pockets, leads, and all portions of ventricular assist devices. This advanced imaging can aid in key medical and surgical considerations. Consensus diagnostic features include focal/multi-focal or diffuse heterogenous intense 18F-FDG uptake on valvular and prosthetic material, perivalvular areas, device pockets and leads, and ventricular assist device hardware persisting on non-attenuation corrected images. There are numerous clinical indications with a larger role in prosthetic valves, and cardiac devices particularly with possible infective endocarditis or in the setting of prior equivocal or non-diagnostic imaging. Illustrative cases incorporating these consensus recommendations provide additional clarification. Future research is necessary to refine application of these advanced imaging tools for surgical planning, to identify treatment response, and more.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiopharmaceuticals / Fluorodeoxyglucose F18 / Consensus / Positron Emission Tomography Computed Tomography Limits: Humans Country/Region as subject: America do norte Language: En Journal: Heart Rhythm Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiopharmaceuticals / Fluorodeoxyglucose F18 / Consensus / Positron Emission Tomography Computed Tomography Limits: Humans Country/Region as subject: America do norte Language: En Journal: Heart Rhythm Year: 2024 Document type: Article